{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:43:17Z","timestamp":1786120997861,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cld.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:27:19Z","timestamp":1779276439000},"page":"601-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Diagnostic Pathway for Patients with Cholestatic Liver Disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Adrielly","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Grossi Lopes","family":"Can\u00e7ado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","article-title":"Mechanisms of cholestasis","volume":"12","author":"Zollner","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1089-3261(03)00028-X","article-title":"Bile duct disorders","volume":"7","author":"Geubel","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"6173","key":"10.1016\/j.cld.2026.04.002_bib3","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/bmj.1.6173.1232","article-title":"Diagnosis of cholestasis","volume":"1","year":"1979","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib4","doi-asserted-by":"crossref","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-025-00600-x","article-title":"Primary sclerosing cholangitis","volume":"11","author":"Manns","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10620-022-07581-x","article-title":"Impact of pruritus on quality of life and current treatment patterns in patients with primary biliary cholangitis","volume":"68","author":"Mayo","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/hep.27582","article-title":"The pruritus of cholestasis: facts","volume":"61","author":"Bergasa","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.26909","article-title":"Pruritus in cholestasis: facts and fiction","volume":"60","author":"Beuers","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOG.0b013e32834575e8","article-title":"Mediators of pruritus during cholestasis","volume":"27","author":"Oude Elferink","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-022-00687-7","article-title":"Mechanisms of pruritus in cholestasis: understanding and treating the itch","volume":"20","author":"Beuers","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2024.04.008","article-title":"Assessment of fatigue and its impact in chronic liver disease","volume":"81","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/00325481.1991.11701060","article-title":"Jaundice and cholestasis. Some common and uncommon causes","volume":"90","author":"Gordon","year":"1991","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib15","first-page":"164","article-title":"Evaluation of Jaundice in adults","volume":"95","author":"Fargo","year":"2017","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1089-3261(03)00032-1","article-title":"Drug-induced cholestasis","volume":"7","author":"Levy","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cld.2015.08.009","article-title":"Total parenteral nutrition-induced cholestasis: prevention and management","volume":"20","author":"Beath","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0272-2712(18)30270-1","article-title":"Ethanol and hepatocellular injury","volume":"16","author":"French","year":"1996","journal-title":"Clin Lab Med"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cld.2018.12.007","article-title":"Rheumatologic diseases and the liver","volume":"23","author":"Gebreselassie","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12876-025-03852-9","article-title":"Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis","volume":"25","author":"Egbaria","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2023.11.028","article-title":"Genetic cholestasis in children and adults","volume":"80","author":"Nayagam","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhep.2004.12.014","article-title":"Cholestatic hepatocellular injury: what do we know and how should we proceed","volume":"42","author":"Guicciardi","year":"2005","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2013.09.005","article-title":"Evaluation of abnormal liver tests","volume":"98","author":"Woreta","year":"2014","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.cld.2026.04.002_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bpg.2010.07.007","article-title":"Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)","volume":"24","author":"Strassburg","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2026.04.002_bib25","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","article-title":"Abnormal liver enzymes: a review for clinicians","volume":"13","author":"Kalas","year":"2021","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOG.0000000000000447","article-title":"Evaluation of abnormal liver tests in the adult asymptomatic patient","volume":"34","author":"Schreiner","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.002_bib27","first-page":"43","article-title":"Biomarkers for primary biliary cholangitis: current perspectives","volume":"10","author":"Kouroumalis","year":"2018","journal-title":"Hepat Med"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cld.2023.07.002","article-title":"Autoimmune markers in primary biliary cholangitis","volume":"28","author":"Shah","year":"2024","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature","volume":"56","author":"de Liso","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jgh.14900","article-title":"IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate","volume":"35","author":"Takano","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/2050640620934911","article-title":"European guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr","year":"2020","journal-title":"United Eur Gastroenterol J"},{"issue":"5","key":"10.1016\/j.cld.2026.04.002_bib37","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2026.04.002_bib38","article-title":"Imaging of biliary tree abnormalities","volume":"44","author":"Lopes","year":"2024","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0039-1687853","article-title":"Magnetic resonance imaging in primary sclerosing cholangitis-current state and future directions","volume":"39","author":"Zenouzi","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.suc.2024.06.001","article-title":"Imaging evaluation of the biliary tree","volume":"104","author":"Fursevich","year":"2024","journal-title":"Surg Clin North Am"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s003300050486","article-title":"MR cholangiography: techniques and clinical applications","volume":"8","author":"Pavone","year":"1998","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1148\/rg.296095514","article-title":"MR imaging and CT of the biliary tract","volume":"29","author":"Yeh","year":"2009","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s12328-021-01419-1","article-title":"The new era of endoscopic ultrasound in biliary disorders","volume":"14","author":"Lesmana","year":"2021","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cld.2021.08.006","article-title":"Role of endoscopic retrograde cholangiopancreatography in the diagnosis and management of cholestatic liver diseases","volume":"26","author":"Keihanian","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cld.2018.03.008","article-title":"Liver biopsy in primary biliary cholangitis: indications and interpretation","volume":"22","author":"Tan","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2026.04.002_bib47","first-page":"23","article-title":"[Liver biopsy in cholestasis]","author":"Bruguera","year":"1981","journal-title":"Acta Med Port"},{"issue":"8","key":"10.1016\/j.cld.2026.04.002_bib48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib49","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.1840150429","article-title":"Transjugular liver biopsy","volume":"15","author":"McAfee","year":"1992","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2026.04.002_bib50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.32074\/1591-951X-245","article-title":"Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-8278(01)00094-0","article-title":"Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology","volume":"35","author":"Skelly","year":"2001","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","article-title":"The utility of liver biopsy in 2020","volume":"36","author":"Khalifa","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.002_bib54","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2023.08.005","article-title":"IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies","volume":"79","author":"Kersten","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2026.04.002_bib55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.semdp.2023.11.005","article-title":"Challenges and pitfalls in the diagnosis of IgG4-related disease","volume":"41","author":"Bateman","year":"2024","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MOG.0000000000000908","article-title":"Histological evaluation in biliary diseases","volume":"39","author":"Saffioti","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2026.04.002_bib58","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cld.371","article-title":"Liver histology in the diagnosis and prognosis of drug-induced liver injury","volume":"4","author":"Kleiner","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2026.04.002_bib60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2021.12.043","article-title":"Value of liver biopsy in the diagnosis of drug-induced liver injury","volume":"76","author":"Ahmad","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2026.04.002_bib62","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0168-8278(99)80302-X","article-title":"Anti-pyruvate dehydrogenase autoantibodies in extrahepatic disorders","volume":"31","author":"Zamfir","year":"1999","journal-title":"J Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2026.04.002_bib63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap syndromes","volume":"33","author":"Chazouill\u00e8res","year":"2015","journal-title":"Dig Dis"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cld.2018.03.010","article-title":"Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis","volume":"22","author":"To","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib65","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib67","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/tomography10010005","article-title":"Primary sclerosing cholangitis: diagnostic criteria","volume":"10","author":"Cazzagon","year":"2024","journal-title":"Tomography"},{"key":"10.1016\/j.cld.2026.04.002_bib69","article-title":"Clinical and prognostic factors associated with inflammatory bowel disease in a highly admixed population with primary sclerosing cholangitis","author":"Nardelli","year":"2025","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2026.04.002_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000590","article-title":"Management of primary sclerosing cholangitis: current state-of-the-art","volume":"8","author":"Can\u00e7ado","year":"2024","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gtc.2017.01.008","article-title":"Autoimmune hepatitis overlap syndromes and liver pathology","volume":"46","author":"Czaja","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"issue":"8","key":"10.1016\/j.cld.2026.04.002_bib72","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/ueg2.70081","article-title":"Adherence to United European Gastroenterology Guidelines on diagnosis and therapy of Immunoglobulin-G4-Related digestive disease","volume":"13","author":"Vujasinovic","year":"2025","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib73","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib74","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3350\/kjhep.2011.17.1.76","article-title":"IgG4-related sclerosing cholangitis: liver biopsy findings","volume":"17","author":"Ryu","year":"2011","journal-title":"Korean J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.002_bib76","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0036-1584321","article-title":"IgG4-Related sclerosing cholangitis","volume":"36","author":"Nakazawa","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2026.04.002_bib77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2024.04.006","article-title":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"15","key":"10.1016\/j.cld.2026.04.002_bib78","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha(1)-Antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"issue":"11\u201312","key":"10.1016\/j.cld.2026.04.002_bib79","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/apt.16118","article-title":"Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1","volume":"52","author":"Nayagam","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","volume":"64","author":"Fawaz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.cld.2026.04.002_bib81","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep4.1871","article-title":"High-resolution exposomics and metabolomics reveals specific associations in cholestatic liver diseases","volume":"6","author":"Walker","year":"2022","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.cld.2026.04.002_bib82","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000496","article-title":"Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease","volume":"8","author":"Juran","year":"2024","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-024-01803-x","article-title":"Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis","volume":"17","author":"Noble","year":"2025","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib84","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/hepr.13867","article-title":"Automated image analysis of keratin 7 staining can predict disease outcome in primary sclerosing cholangitis","volume":"53","author":"Sj\u00f6blom","year":"2023","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib85","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jpn3.70166","article-title":"A prediction model for genetic cholestatic disease in infancy using the machine learning approach","volume":"81","author":"Tai","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.cld.2026.04.002_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s41747-022-00312-x","article-title":"Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis","volume":"6","author":"Singh","year":"2022","journal-title":"Eur Radiol Exp"},{"issue":"4","key":"10.1016\/j.cld.2026.04.002_bib87","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/hep4.1860","article-title":"A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis","volume":"6","author":"Selvaraj","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612600036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612600036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:41:51Z","timestamp":1786070511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932612600036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S108932612600036X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Diagnostic Pathway for Patients with Cholestatic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}